Tim Schaper

Counsel
Norton Rose Fulbright LLP

Tim Schaper

Tim Schaper

vCard

Biography

Dr. Tim Schaper is a competition lawyer based in Hamburg. He advises national and multinational clients on German and European competition law.

Tim's practice focuses on advising clients on cartel investigations, abuse-of-dominance cases and merger control proceedings before the German Federal Cartel Office and the European Commission as well as on representing clients in cartel damages proceedings before German courts.

Tim provides competition law advice on both horizontal co-operations and vertical distribution and supply agreements. His practice also comprises cross-practice advice on complex antitrust law questions relating to the thematic interface of IP and antitrust law, such as advice on technology transfer and research and development agreements.

Tim develops and designs customised and cost-effective compliance programs, including competition law compliance training sessions and audits.

Tim holds a law degree and a doctoral degree from the University of Goettingen and has studied in Göttingen and abroad at the University of Leiden in the Netherlands.

Prior to joining us in the beginning of 2016, he worked in the competition law practices of leading international law firms in Düsseldorf and Hamburg.

Tim regularly publishes articles on competition law and is a member of the German Association for the Study of Antitrust Law (Studienvereinigung Kartellrecht).


Professional experience

Expand all Collapse all
  • Rechtsanwalt
  • German insurance companies Gothaer, Debeka, HUK-Coburg, Barmenia und Stuttgarter - advised on the establishment of a joint venture offering company pension schemes.
  • W&W – advised on its acquisition of Aachener Bausparkasse.
  • J.W. Ostendorf - advised on the sale of its paint business to its competitor Hempel.
  • Liberty House Group – advised on its acquisition of AR Industries.
  • Gränges – advised on its acquisition of shares in Erbslöh Aluminium.
  • CAE - advised on its acquisition of Lockheed Martin's flight simulator division.
  • Samsung SDI - advised on its acquisition of Magna's automotive li-ion battery business.
  • Baltisse – advised on the sale of its international flooring business to its competitor Mohawk.
  • ThyssenKrupp – advised on the divestment of its stainless steel business to its competitor Outokumpu and on the sale of its civil and military shipbuilding activities to competitor Abu Dhabi MAR.
  • Antitrust Law Firm of the year JUVE Award Nomination 2019
  • Competition Future Leader GCR – Who's Who Legal: Competition 2019
  • Kartellrecht, WirtschaftsWoche TOP Kanzleien 2018
  • Higher Regional Court considers narrow best price clause in hotel booking sector to be in line with competition law requirements, judgment review of OLG Düsseldorf, Beschl. v. 4.6.2019 (VI-Kart 2/16(V)), Newsdienst Compliance, issue number 7, 31 July 2019
  • Judgment of the ECJ regarding questions concerning the parallel use of the EU-legislative definition of an undertaking in antitrust fine - and damages law, judgment review of ECJ (Rs. C-724/17) Newsdienst Compliance, issue number 03, March 14 2019
  • Cartel members faced with impending stricter liability – the Advocate General of the ECJ pleads for a more effective enforcement of damages, Interview in Börsen-Zeitung, issue number 43, March 2 2019, page 9
  • CFI has to review the antitrust fine against Infineon, judgment review of ECJ, judgment of (Rs. C-99/17), Newsdienst Compliance, issue number 10, September 26, 2018
  • ECJ specifies the standards of a discrimination of a trade partner in competition within the meaning of Art. 102 (2) (c) TFEU by a market-dominating company, judgment review of  ECJ, judgment of 19 April 2018 (Rs. C-525/16), Newsdienst Compliance, issue number 4
  • Judgment of the ECJ regarding the illegality of the German price fixing for prescription drugs of the human medicine, judgement review of  ECJ, judgment of October 19, 2016 (Rs. C-148/15), Newsdienst Compliance, issue number 11
  • Co-author with Dr. Maxim Kleine, Getting the Deal Through, Pharmaceutical Antitrust Germany, 2016 and 2017
  • Co-author with Dr. Florian Haus, The AMNOG reform; changes to the competition law rules in the German health sector, ZWeR 2011, page 48 
  • Challenges under constitutional law arising from the transfer of sovereign rights to create a single body of European criminal law, Univ. Diss, Duncker & Humblot, 2009.
  • Member of the German Association for the Study of Antitrust Law (Studienvereinigung Kartellrecht)
  • Norton Rose Fulbright LLP / Antitrust and Competition - Member of Hamburg Industry Association (Industrieverband Hamburg - IVH)
  • English
  • German